Receipt of formal meeting minutes from the FDA confirming key elements for two proposed Phase 3 pivotal trials indicates regulatory progress and alignment with the FDA. Positive outcome of the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback